Cytokinetics Inc: director John T Henderson received 352 shares

What happened John T Henderson, a director of Cytokinetics Inc, received 352 shares as an award/acquisition at $63.92 per share, for a total of $22,500, according to the Form 4 covering Oct 16, 2026.

Key details

• Transaction date and price: Oct 16, 2026; 352 shares at $63.92 per share.
• Total value reported: $22,500.
• Shares owned after the transaction: not reported on the Form 4.
• Footnote F1: director equity in lieu of cash retainer program.
• Filing date: Oct 20, 2026; timeliness not indicated in the filing.

Why it may matter

• The Form 4 reports an award/grant (transaction code A), so this was an acquisition of shares rather than a market purchase or sale.
• A filing does not show why the insider traded or why the company acted.